The company has received US FDA approval for Alzheimer drug Rivastigmine Tartrate
Orchid Chemical & Pharmaceuticals has soared 6.9 percent to a high at Rs. 45.75 in early trades on the BSE on media reports the company has received US FDA approval for Alzheimer drug Rivastigmine Tartrate
The stock is now up 5 percent at Rs. 45.15. The BSE counter has registered trades of around 116,000 shares, as against two-week daily average volume of 76,000 shares.
Meanwhile, the Sensex is up 16 points at 26,387.
The stock is now up 5 percent at Rs. 45.15. The BSE counter has registered trades of around 116,000 shares, as against two-week daily average volume of 76,000 shares.
Meanwhile, the Sensex is up 16 points at 26,387.
No comments:
Post a Comment